The company's purpose is to engage in research, development, production, licensing, and distribution of solutions in the field of end-of-life technologies. It may carry out all related commercial activities. The company may establish branches and subsidiaries in Switzerland and/or abroad, participate in other companies in Switzerland and/or abroad, acquire, hold, encumber, and dispose of real estate or intellectual property rights in Switzerland and/or abroad, and conduct all commercial, financial, or other transactions that are directly or indirectly related to the company's purpose. Furthermore, the company may grant loans or other financing, with or without compensation, to its direct or indirect shareholders, their direct or indirect subsidiaries, and third parties, and provide security of all kinds for the liabilities of such persons or group companies, including guarantees, pledges, and fiduciary transfers of the company's assets. Additionally, the company may engage in or participate in liquidity equalization/net liquidity centralization (cash pooling), including periodic balance adjustments (balancing), with group companies, without consideration, at preferential terms, interest-free, without the intention of making a profit, and assuming clumping risks.